Newfound Research’s Elevance Health ELV Stock Holding History

Newfound Research’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10	Closed	-$2K	–	88
2020 Q1	$2K	Hold	10	–	–	﹤0.01%	37
2019 Q4	$3K	Sell	10 -7	-41%	-$1.93K	﹤0.01%	71
2019 Q3	$4K	Sell	17 -1	-6%	-$274	﹤0.01%	74
2019 Q2	$5K	Sell	18 -1	-5%	-$273	﹤0.01%	62
2019 Q1	$5K	Sell	19 -2	-10%	-$578	﹤0.01%	52
2018 Q4	$5K	Sell	21 -1	-5%	-$275	﹤0.01%	34
2018 Q3	$6K	Sell	22 -1	-4%	-$260	﹤0.01%	64
2018 Q2	$5K	Sell	23 -1	-4%	-$232	﹤0.01%	56
2018 Q1	$5K	Buy	24 +3	+14%	+$705	﹤0.01%	57
2017 Q4	$5K	Sell	21 -1	-5%	-$213	﹤0.01%	71
2017 Q3	$4K	Hold	22	–	–	﹤0.01%	69
2017 Q2	$4K	Buy	22 +1	+5%	+$180	﹤0.01%	75
2017 Q1	$4K	Sell	21 -1	-5%	-$159	﹤0.01%	75
2016 Q4	$3K	Sell	22 -1	-4%	-$134	﹤0.01%	70
2016 Q3	$3K	Hold	23	–	–	﹤0.01%	81
2016 Q2	$3K	Buy	+23	New	+$3.15K	﹤0.01%	74

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Newfound Research's ELV Position: Q2 2020 in Review

Newfound Research sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 10 shares — an estimated $2K sold.

Newfound Research first reported a position in ELV in Q2 2016 and held it in 16 quarters. The position peaked at $6K in Q3 2018. 1,108 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

Newfound Research reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
Newfound Research sold 10 Elevance Health shares in Q2 2020, an estimated $2K.
Newfound Research first reported a position in Elevance Health in Q2 2016 and held it in 16 quarters.
Newfound Research's Elevance Health position peaked at $6K in Q3 2018.
1,108 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on Newfound Research's 13F filing for Q2 2020, filed 10 Aug 2020.